New Key Statistics Module, Z-Score and F-Score
XTAE:DNA Key Ratios
| Market Cap ₪ M | 115.41 |
| Enterprise Value ₪ M | 48.71 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 187.40 |
| Forward PE Ratio | -- |
| Price/Book | 1.46 |
| Price/Sales | 468.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ₪ M | -- |
| EPS (TTM) ₪ | -0.01 |
| Beneish M-Score | 5.11 |
| 10-y EBITDA Growth Rate % | 29.40 |
| 5-y EBITDA Growth Rate % | 55.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -22.40 |
| EV-to-EBITDA | -22.40 |
| PEG | 3.37 |
| Shares Outstanding M | 123.16 |
| Net Margin (%) | -384.64 |
| Operating Margin % | -710.46 |
| Pre-tax Margin (%) | -384.64 |
| Quick Ratio | 97.73 |
| Current Ratio | 97.73 |
| ROA % (ttm) | -1.43 |
| ROE % (ttm) | -1.46 |
| ROIC % (ttm) | -13.62 |
| Dividend Yield % | -- |
| Altman Z-Score | 48.01 |
XTAE:DNA Number of Guru Trades
XTAE:DNA Volume of Guru Trades
Gurus Latest Trades with XTAE:DNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XTAE:DNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers